We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

PolyPeptide Group AG (PPGN) CHF0.01

Sell:28.75 CHF Buy:30.20 CHF Change: 0.70 CHF (2.43%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:28.75 CHF
Buy:30.20 CHF
Change: 0.70 CHF (2.43%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:28.75 CHF
Buy:30.20 CHF
Change: 0.70 CHF (2.43%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.

Contact details

Address:
Neuhofstrasse 24
BAAR
6340
Switzerland
Telephone:
+41 (43) 5020580
Website:
https://www.polypeptide.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PPGN
ISIN:
CH1110760852
Market cap:
955.48 million CHF
Shares in issue:
32.97 million
Sector:
Life Sciences Tools & Services
Exchange:
SIX Swiss Exchange
Country:
Switzerland
Currency:
Swiss Franc
Indices:
Swiss All Share Index

Key personnel

  • Juan-Jose Gonzalez
    Chief Executive Officer
  • Marc Augustin
    Chief Financial Officer
  • Christina Del Vecchio
    General Counsel, Corporate Secretary
  • Neil Thompson
    Director Global Sales and Marketing
  • Jens Fricke
    Director Global Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.